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ABSTRACT  Background/Aims: We examined the usefulness of the leukocyte migration test 
(LMT) in the identiÞ cation of agents causing drug-induced liver injury (DILI). Methodology: 
In 14 patients who were tentatively diagnosed as having DILI in Kitasato Institute Hospital, 
pharmacists collected and evaluated drug information and patients’ medication histories to 
identify causative agents. Simultaneously, LMT and drug lymphocyte stimulation test (DLST) 
were performed. Furthermore, scoring was performed according to the diagnostic criteria 
established by the International Consensus Meeting (ICM) and the Digestive Disease Week-
Japan 2004 (DDW-J). Results: LMT-positive agents showed a higher ICM score compared 
to DLST-positive agents. The rate of LMT-positive agents was examined with respect to 
ICM assessment,  and 0%, 25%, 33%, and 100% of agents regarded as unrelated/unlikely, 
possible, probable, and highly probable showed positive reactions in LMT, respectively; the 
rate of LMT-positive agents increase with the degree of the agent’s involvement. When the 
results of LMT were applied to the DDW-J criteria, there was a correlation with the ICM 
criteria in comparison to scoring based on the results of DLST. Conclusions: LMT may be 
useful for identifying agents causing DILI. Furthermore, the collection and evaluation of 
drug and patient information and in vitro testing in the identiÞ cation of causative agents may 
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